Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Cancer of the Uterus

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Cancer of the Uterus in 2 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malik, M1
Britten, J1
Segars, J1
Catherino, WH1
Fujisawa, K1
Nasu, K1
Arima, K1
Sugano, T1
Narahara, H1
Miyakawa, I1

Other Studies

2 other studies available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Cancer of the Uterus

ArticleYear
Leiomyoma cells in 3-dimensional cultures demonstrate an attenuated response to fasudil, a rho-kinase inhibitor, when compared to 2-dimensional cultures.
    Reproductive sciences (Thousand Oaks, Calif.), 2014, Volume: 21, Issue:9

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cell Culture Techniques; Cell Line, Transfor

2014
Production of interleukin (IL)-6 and IL-8 by a choriocarcinoma cell line, BeWo.
    Placenta, 2000, Volume: 21, Issue:4

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Blotting, Northern; Choriocarcinoma; Dexametha

2000